Skip to main content
Top
Published in: International Urology and Nephrology 4/2012

01-08-2012 | Nephrology - Original Paper

Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography

Authors: Gholamreza Davoodi, Samira Mehrabi Pari, Mehrnaz Rezvanfard, Mahmood Sheikh Fathollahi, Manouchehr Amini, Elham Hakki, Ali Kazemisaeid, Ahmad Yaminisharif

Published in: International Urology and Nephrology | Issue 4/2012

Login to get access

Abstract

Purpose

Chronic kidney disease is independently associated with an increased risk of cardiovascular events; however, the relationship between the glomerular filtration rate (GFR) and coronary artery disease (CAD) in patients undergoing coronary angiography has yet to be fully elucidated.

Methods

This retrospective study enrolled a total of 7968 patients who underwent diagnostic coronary artery catheterization [mean age = 54.8 ± 10.6 years, 74.4% males] and did not have any previous history of coronary revascularization, diabetes mellitus, hypertension, end-stage renal disease treated by dialysis or renal transplantation, and were not taking diuretics or drugs acting on renin angiotensin system. The severity of CAD was defined as the number of coronary arteries with a luminal stenosis ≥50% on the angiogram, and the GFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI).

Results

There were 2133 (26.8%) patients with GFR ≥ 90 ml/min/1.73 m2, 4574 (57.4%) patients with 60 ≤ GFR < 90 ml/min/1.73 m2, 1073 (13.5%) with 45 ≤ GFR < 60 ml/min/1.73 m2 and 181 (2.3%) with 15 < GFR < 45 ml/min/1.73 m2. After adjustment for traditional cardiovascular risk factors (age, sex, dyslipidemia, low to high-density lipoprotein ratio, smoking status, and family history), the GFR showed a significant association with the severity of CAD and remained a significant predictor of CAD (Odds Ratio raised from 1.1 in patients with 60 ≤ GFR < 90 ml/min/1.73 m2 to 1.8 in patients with 15 < GFR < 45 ml/min/1.73 m2).

Conclusions

A reduced kidney function, even mildly, is significantly associated with CAD severity, independently of other traditional CAD risk factors.
Literature
1.
go back to reference Sarnak MJ, Coronado BE, Greene T, Wang SR, Kusek JW, Beck GJ et al (2002) Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol 57:327–335PubMed Sarnak MJ, Coronado BE, Greene T, Wang SR, Kusek JW, Beck GJ et al (2002) Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol 57:327–335PubMed
2.
go back to reference Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG et al (1989) Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension detection and follow-up program cooperative group. Hypertension 13:I80–I193PubMed Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG et al (1989) Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension detection and follow-up program cooperative group. Hypertension 13:I80–I193PubMed
3.
go back to reference Solak Y, Akilli H, Atalay H, Kayrak M, Gok H, Turk S (2010) The association of glomerular filtration rate and erectile dysfunction with severity of coronary artery disease in patients presenting with chest pain. Int Urol Nephrol 42:765–771 Solak Y, Akilli H, Atalay H, Kayrak M, Gok H, Turk S (2010) The association of glomerular filtration rate and erectile dysfunction with severity of coronary artery disease in patients presenting with chest pain. Int Urol Nephrol 42:765–771
4.
go back to reference Muntner P, He J, Hamm L, Loria C, Whelton PK (2002) Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13:745–753PubMed Muntner P, He J, Hamm L, Loria C, Whelton PK (2002) Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13:745–753PubMed
5.
go back to reference Beddhu S, Allen-Brady K, Cheung AK, Horne BD, Bair T, Muhlestein JB et al (2002) Impact of renal failure on the risk of myocardial infarction and death. Kidney Int 62:1776–1783PubMedCrossRef Beddhu S, Allen-Brady K, Cheung AK, Horne BD, Bair T, Muhlestein JB et al (2002) Impact of renal failure on the risk of myocardial infarction and death. Kidney Int 62:1776–1783PubMedCrossRef
6.
go back to reference Henry RMA, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ et al (2002) Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int 62:1402–1407PubMedCrossRef Henry RMA, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ et al (2002) Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int 62:1402–1407PubMedCrossRef
7.
go back to reference Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Eng J Med 351:1296–1305CrossRef Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Eng J Med 351:1296–1305CrossRef
8.
go back to reference Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL et al (2003) Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 63:1121–1129PubMedCrossRef Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL et al (2003) Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 63:1121–1129PubMedCrossRef
9.
go back to reference Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuf S (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134:629–636PubMed Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuf S (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134:629–636PubMed
10.
go back to reference Best PJM, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR Jr et al (2002) The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39:1113–1119PubMedCrossRef Best PJM, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR Jr et al (2002) The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39:1113–1119PubMedCrossRef
11.
go back to reference Wison S, Foo K, Cunningham J, Cooper J, Deaner A, Knight C et al (2003) Renal function and risk stratification in acute coronary syndromes. Am J Cardiol 91:1051–1054PubMedCrossRef Wison S, Foo K, Cunningham J, Cooper J, Deaner A, Knight C et al (2003) Renal function and risk stratification in acute coronary syndromes. Am J Cardiol 91:1051–1054PubMedCrossRef
12.
go back to reference Jungers P, Massy ZA, Nguyen Khoa T, Fumeron C, Labrunie M, Lacour B et al (1997) Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 12:2597–2602PubMedCrossRef Jungers P, Massy ZA, Nguyen Khoa T, Fumeron C, Labrunie M, Lacour B et al (1997) Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 12:2597–2602PubMedCrossRef
13.
go back to reference Reis SE, Olson MB, Fried L, Reeser V, Mankad S, Pepine CJ et al (2002) Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation 105:2826–2829PubMedCrossRef Reis SE, Olson MB, Fried L, Reeser V, Mankad S, Pepine CJ et al (2002) Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation 105:2826–2829PubMedCrossRef
14.
go back to reference Khalique O, Aronow WS, Ahn C, Mazar M, Schair B, Shao J et al (2007) Relation of moderate or severe reduction in glomerular filtration rate to number of coronary arteries narrowed >50% in patients undergoing coronary angiography for suspected coronary artery disease. Am J Cardiol 100:415–416PubMedCrossRef Khalique O, Aronow WS, Ahn C, Mazar M, Schair B, Shao J et al (2007) Relation of moderate or severe reduction in glomerular filtration rate to number of coronary arteries narrowed >50% in patients undergoing coronary angiography for suspected coronary artery disease. Am J Cardiol 100:415–416PubMedCrossRef
15.
go back to reference Garg AX, Clark WF, Haynes RB, House AA (2002) Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int 61:1486–1494PubMedCrossRef Garg AX, Clark WF, Haynes RB, House AA (2002) Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int 61:1486–1494PubMedCrossRef
16.
go back to reference Culleton BF, Larson MG, Wilson PWF, Evans JC, Parfrey PS, Levy D (1999) Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56:2214–2219PubMedCrossRef Culleton BF, Larson MG, Wilson PWF, Evans JC, Parfrey PS, Levy D (1999) Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56:2214–2219PubMedCrossRef
17.
go back to reference Brancati FL, Whelton P, Randali B (1997) Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRIIF. Multiple risk factor intervention trial. JAMA 278:2069–2074PubMedCrossRef Brancati FL, Whelton P, Randali B (1997) Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRIIF. Multiple risk factor intervention trial. JAMA 278:2069–2074PubMedCrossRef
18.
go back to reference Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE et al (1996) Blood pressure and end-stage renal disease in men. N Engl J Med 334:13–18PubMedCrossRef Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE et al (1996) Blood pressure and end-stage renal disease in men. N Engl J Med 334:13–18PubMedCrossRef
19.
go back to reference Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA et al (1999) ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 33:1756–1824PubMedCrossRef Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA et al (1999) ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 33:1756–1824PubMedCrossRef
20.
go back to reference Cirillo M (2010) Evaluation of glomerular filtration rate and of albuminuria/proteinuria. J Nephrol 23:125–132PubMed Cirillo M (2010) Evaluation of glomerular filtration rate and of albuminuria/proteinuria. J Nephrol 23:125–132PubMed
21.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612PubMed Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612PubMed
22.
go back to reference Eknoyan G, Levin NW, K/DOQI (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:1–266CrossRef Eknoyan G, Levin NW, K/DOQI (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:1–266CrossRef
24.
25.
go back to reference Sarnak MJ, Levey AS (2000) Cardiovascular disease, chronic renal disease: a new paradigm. Am J Kidney Dis 35:117–131CrossRef Sarnak MJ, Levey AS (2000) Cardiovascular disease, chronic renal disease: a new paradigm. Am J Kidney Dis 35:117–131CrossRef
26.
go back to reference Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP et al (2003) Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107:87–92PubMedCrossRef Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP et al (2003) Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107:87–92PubMedCrossRef
27.
go back to reference Knight EL, Rimm EB, Pai JK, Rexrode KM, Cannuscio CC, Manson JAE et al (2004) Kidney dysfunction, inflammation, and coronary events: a prospective study. J Am Soc Nephrol 15:1897–1903PubMedCrossRef Knight EL, Rimm EB, Pai JK, Rexrode KM, Cannuscio CC, Manson JAE et al (2004) Kidney dysfunction, inflammation, and coronary events: a prospective study. J Am Soc Nephrol 15:1897–1903PubMedCrossRef
28.
go back to reference Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648–658PubMedCrossRef Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648–658PubMedCrossRef
29.
go back to reference Zebrack JS, Anderson JL, Beddhu S, Horne BD, Bair TL, Cheung A et al (2003) Do associations with C-Reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency? J Am Coll Cardiol 42:57–63PubMedCrossRef Zebrack JS, Anderson JL, Beddhu S, Horne BD, Bair TL, Cheung A et al (2003) Do associations with C-Reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency? J Am Coll Cardiol 42:57–63PubMedCrossRef
30.
go back to reference Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ (2006) Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 151:492–500PubMedCrossRef Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ (2006) Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 151:492–500PubMedCrossRef
31.
go back to reference Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112:2627–2633PubMedCrossRef Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112:2627–2633PubMedCrossRef
32.
go back to reference Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D et al (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478–1483PubMedCrossRef Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D et al (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478–1483PubMedCrossRef
33.
go back to reference Lishmanov A, Dorairajan S, Pak Y, Chaudhary K, Chockalingam A (2011) Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease. Int Urol Nephrol 43:161–173 Lishmanov A, Dorairajan S, Pak Y, Chaudhary K, Chockalingam A (2011) Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease. Int Urol Nephrol 43:161–173
34.
go back to reference Koenig W, Twardella D, Brenner H, Rothenbacher D (2005) Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 51:321–327PubMedCrossRef Koenig W, Twardella D, Brenner H, Rothenbacher D (2005) Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 51:321–327PubMedCrossRef
35.
go back to reference Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S (1999) Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Internal Med 131:363–375 Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S (1999) Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Internal Med 131:363–375
36.
go back to reference Bostom AG, Lathrop L (1997) Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52:10–20PubMedCrossRef Bostom AG, Lathrop L (1997) Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52:10–20PubMedCrossRef
37.
go back to reference Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Madsen TE et al (2000) Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation 102:1227–1232PubMedCrossRef Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Madsen TE et al (2000) Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation 102:1227–1232PubMedCrossRef
38.
go back to reference Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. JAMA 283:2404–2410PubMedCrossRef Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. JAMA 283:2404–2410PubMedCrossRef
39.
go back to reference Gesquière L, Loreau N, Minnich A, Davignon J, Blache D (1999) Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells. Free Radic Biol Med 27:134–145PubMedCrossRef Gesquière L, Loreau N, Minnich A, Davignon J, Blache D (1999) Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells. Free Radic Biol Med 27:134–145PubMedCrossRef
40.
go back to reference Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG (1999) Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans. Circulation 100:1161–1168PubMedCrossRef Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG (1999) Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans. Circulation 100:1161–1168PubMedCrossRef
41.
go back to reference Koch M, Kutkuhn B, Trenkwalder E, Bach D, Grabensee B, Dieplinger H et al (1997) Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein (a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 8:1889–1898PubMed Koch M, Kutkuhn B, Trenkwalder E, Bach D, Grabensee B, Dieplinger H et al (1997) Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein (a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 8:1889–1898PubMed
42.
go back to reference Muntner P, He J, Astor BC, Folsom AR, Coresh J (2005) Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol 16:529–538PubMedCrossRef Muntner P, He J, Astor BC, Folsom AR, Coresh J (2005) Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol 16:529–538PubMedCrossRef
43.
go back to reference Romanic AM, Arleth AJ, Willette RN, Ohlstein EH (1998) Factor XIIIa cross-links lipoprotein (a) with fibrinogen and is present in human atherosclerotic lesions. Circ Res 83:264–269PubMedCrossRef Romanic AM, Arleth AJ, Willette RN, Ohlstein EH (1998) Factor XIIIa cross-links lipoprotein (a) with fibrinogen and is present in human atherosclerotic lesions. Circ Res 83:264–269PubMedCrossRef
44.
go back to reference Sechi LA, Zingaro L, Catena C, De Marchi S (2000) Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: association with cardiovascular events. J Thromb Haemost 84:565–570 Sechi LA, Zingaro L, Catena C, De Marchi S (2000) Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: association with cardiovascular events. J Thromb Haemost 84:565–570
Metadata
Title
Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography
Authors
Gholamreza Davoodi
Samira Mehrabi Pari
Mehrnaz Rezvanfard
Mahmood Sheikh Fathollahi
Manouchehr Amini
Elham Hakki
Ali Kazemisaeid
Ahmad Yaminisharif
Publication date
01-08-2012
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 4/2012
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-011-0070-3

Other articles of this Issue 4/2012

International Urology and Nephrology 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine